{
    "clinical_study": {
        "@rank": "141109", 
        "arm_group": [
            {
                "arm_group_label": "hyperglycemia", 
                "arm_group_type": "Experimental", 
                "description": "Hyperglycemic clamping"
            }, 
            {
                "arm_group_label": "hypoglycemia", 
                "arm_group_type": "Experimental", 
                "description": "Hypoglycemic clamping"
            }
        ], 
        "brief_summary": {
            "textblock": "Investigation of Glucose-dependent Insulinotropic Polypeptide (GIP) effects at hyper and\n      hypoglycemia in type 1 diabetes."
        }, 
        "brief_title": "GIP and GLP-1 in Type 1 Diabetes", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypoglycemia", 
        "condition_browse": {
            "mesh_term": "Hypoglycemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        \u2022 Diagnosed with type 1 diabetes (WHO criteria)\n\n        Exclusion Criteria:\n\n          -  HbA1c > 9 %\n\n          -  Liver disease (ALAT/ASAT > 2 x upper normal limit)\n\n          -  Diabetic nephropathy (s-creatinine > 130 \u00b5M or albuminuria)\n\n          -  Proliferative diabetic retinopathy (anamnestic)\n\n          -  Severe arteriosclerosis or heart failure (NYHA group III or IV)\n\n          -  Anemia\n\n          -  treatment with medication not applicable to pause for 12 hours\n\n          -  C-peptide increase after 50 g iv arginine"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739283", 
            "org_study_id": "H-2-2009-078 33269"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "hyperglycemia", 
                    "hypoglycemia"
                ], 
                "intervention_name": "GIP", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "hypoglycemia", 
                "intervention_name": "GLP-1", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "hyperglycemia", 
                    "hypoglycemia"
                ], 
                "intervention_name": "Saline", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 31, 2013", 
        "location": {
            "contact": {
                "last_name": "Mikkel Christensen, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Hellerup", 
                    "country": "Denmark", 
                    "zip": "2900"
                }, 
                "name": "Gentofte Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "other_outcome": [
            {
                "measure": "Glucose and glycerol tracer kinetics", 
                "safety_issue": "No", 
                "time_frame": "approx. 15 minutes intervals, time 0 to 120 min"
            }, 
            {
                "measure": "glucose (g/kg body weight) needed to be infuse to keep clamp", 
                "safety_issue": "No", 
                "time_frame": "approx. 15 minutes intervals, time 0 to 120 min"
            }
        ], 
        "overall_contact": {
            "last_name": "Mikkel Christensen, Christensen", 
            "phone": "+45 39773320"
        }, 
        "overall_official": {
            "affiliation": "Copenhagen University Hospital Gentofte", 
            "last_name": "Mikkel Christensen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "plasma glucagon area under curve values", 
            "safety_issue": "No", 
            "time_frame": "approx. 15 minutes intervals, time 0 to 120 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739283"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Gentofte, Copenhagen", 
            "investigator_full_name": "Mikkel Christensen", 
            "investigator_title": "principal investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "plasma gut hormones and nutrients (absolute, incremental and area under curve values)", 
            "safety_issue": "No", 
            "time_frame": "approx. 15 minutes intervals, time 0 to 120 min"
        }, 
        "source": "University Hospital, Gentofte, Copenhagen", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Mikkel Christensen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}